NCT06079242View on ClinicalTrials.gov

Observational Study for SIR-Spheres Therapy for the Treatment of Unresectable Metastatic Liver Tumors From Primary Colorectal Cancer

Not yet recruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

October 15, 2023

Primary Completion Date

December 30, 2026

Study Completion Date

April 1, 2027

Conditions

Colorectal Neoplasms

Interventions

DEVICE

Resin microspheres containing yttrium-90 (Y-90)

SIR-Spheres Y-90 resin microspheres are permanent implant and for single use only

Trial Locations (1)

310002

Sir Run Run Shaw Hospital (SRRSH), affiliated with the Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors

lead

GrandPharma (China) Co., Ltd.

INDUSTRY

NCT06079242 - Observational Study for SIR-Spheres Therapy for the Treatment of Unresectable Metastatic Liver Tumors From Primary Colorectal Cancer | Biotech Hunter | Biotech Hunter